116 related articles for article (PubMed ID: 7475080)
1. Immune responses against multiple epitopes.
Nowak MA; May RM; Sigmund K
J Theor Biol; 1995 Aug; 175(3):325-53. PubMed ID: 7475080
[TBL] [Abstract][Full Text] [Related]
2. Antigenic oscillations and shifting immunodominance in HIV-1 infections.
Nowak MA; May RM; Phillips RE; Rowland-Jones S; Lalloo DG; McAdam S; Klenerman P; Köppe B; Sigmund K; Bangham CR
Nature; 1995 Jun; 375(6532):606-11. PubMed ID: 7791879
[TBL] [Abstract][Full Text] [Related]
3. CD8 memory, immunodominance, and antigenic escape.
Wodarz D; Nowak MA
Eur J Immunol; 2000 Sep; 30(9):2704-12. PubMed ID: 11009106
[TBL] [Abstract][Full Text] [Related]
4. Selection, transmission, and reversion of an antigen-processing cytotoxic T-lymphocyte escape mutation in human immunodeficiency virus type 1 infection.
Allen TM; Altfeld M; Yu XG; O'Sullivan KM; Lichterfeld M; Le Gall S; John M; Mothe BR; Lee PK; Kalife ET; Cohen DE; Freedberg KA; Strick DA; Johnston MN; Sette A; Rosenberg ES; Mallal SA; Goulder PJ; Brander C; Walker BD
J Virol; 2004 Jul; 78(13):7069-78. PubMed ID: 15194783
[TBL] [Abstract][Full Text] [Related]
5. Cytotoxic T lymphocytes and viral evolution in primary HIV-1 infection.
Price DA; O'callaghan CA; Whelan JA; Easterbrook PJ; Phillips RE
Clin Sci (Lond); 1999 Dec; 97(6):707-18. PubMed ID: 10585898
[TBL] [Abstract][Full Text] [Related]
6. Original antigenic sin impairs cytotoxic T lymphocyte responses to viruses bearing variant epitopes.
Klenerman P; Zinkernagel RM
Nature; 1998 Jul; 394(6692):482-5. PubMed ID: 9697771
[TBL] [Abstract][Full Text] [Related]
7. Dynamic immune responses maintain cytotoxic T lymphocyte epitope mutations in transmitted simian immunodeficiency virus variants.
Barouch DH; Powers J; Truitt DM; Kishko MG; Arthur JC; Peyerl FW; Kuroda MJ; Gorgone DA; Lifton MA; Lord CI; Hirsch VM; Montefiori DC; Carville A; Mansfield KG; Kunstman KJ; Wolinsky SM; Letvin NL
Nat Immunol; 2005 Mar; 6(3):247-52. PubMed ID: 15685174
[TBL] [Abstract][Full Text] [Related]
8. Sequence variation in the influenza A virus nucleoprotein associated with escape from cytotoxic T lymphocytes.
Rimmelzwaan GF; Boon AC; Voeten JT; Berkhoff EG; Fouchier RA; Osterhaus AD
Virus Res; 2004 Jul; 103(1-2):97-100. PubMed ID: 15163496
[TBL] [Abstract][Full Text] [Related]
9. The hypervariable immunodominant NP418-426 epitope from the influenza A virus nucleoprotein is recognized by cytotoxic T lymphocytes with high functional avidity.
Boon AC; de Mutsert G; Fouchier RA; Osterhaus AD; Rimmelzwaan GF
J Virol; 2006 Jun; 80(12):6024-32. PubMed ID: 16731941
[TBL] [Abstract][Full Text] [Related]
10. Influence of polypeptide size and intracellular sorting on the induction of epitope-specific CTL responses by DNA vaccines in a mouse model.
Wild J; Bojak A; Deml L; Wagner R
Vaccine; 2004 Apr; 22(13-14):1732-43. PubMed ID: 15068857
[TBL] [Abstract][Full Text] [Related]
11. Cytotoxic T lymphocytes in asymptomatic long-term nonprogressing HIV-1 infection. Breadth and specificity of the response and relation to in vivo viral quasispecies in a person with prolonged infection and low viral load.
Harrer T; Harrer E; Kalams SA; Barbosa P; Trocha A; Johnson RP; Elbeik T; Feinberg MB; Buchbinder SP; Walker BD
J Immunol; 1996 Apr; 156(7):2616-23. PubMed ID: 8786327
[TBL] [Abstract][Full Text] [Related]
12. Dynamics of viral variants in HIV-1 Nef and specific cytotoxic T lymphocytes in vivo.
Haas G; Plikat U; Debré P; Lucchiari M; Katlama C; Dudoit Y; Bonduelle O; Bauer M; Ihlenfeldt HG; Jung G; Maier B; Meyerhans A; Autran B
J Immunol; 1996 Nov; 157(9):4212-21. PubMed ID: 8892659
[TBL] [Abstract][Full Text] [Related]
13. Reversion of CTL escape-variant immunodeficiency viruses in vivo.
Friedrich TC; Dodds EJ; Yant LJ; Vojnov L; Rudersdorf R; Cullen C; Evans DT; Desrosiers RC; Mothé BR; Sidney J; Sette A; Kunstman K; Wolinsky S; Piatak M; Lifson J; Hughes AL; Wilson N; O'Connor DH; Watkins DI
Nat Med; 2004 Mar; 10(3):275-81. PubMed ID: 14966520
[TBL] [Abstract][Full Text] [Related]
14. Epitope down-modulation as a mechanism for the coexistence of competing T-cells.
Scherer A; Bonhoeffer S
J Theor Biol; 2005 Apr; 233(3):379-90. PubMed ID: 15652147
[TBL] [Abstract][Full Text] [Related]
15. Peptide immunogens designed to enhance immune responses against human immunodeficiency virus (HIV) mutant strains: a plausible means of preventing viral persistence.
Hewer R; Meyer D
J Theor Biol; 2005 Mar; 233(1):85-90. PubMed ID: 15615622
[TBL] [Abstract][Full Text] [Related]
16. Molecular and functional analysis of a conserved CTL epitope in HIV-1 p24 recognized from a long-term nonprogressor: constraints on immune escape associated with targeting a sequence essential for viral replication.
Wagner R; Leschonsky B; Harrer E; Paulus C; Weber C; Walker BD; Buchbinder S; Wolf H; Kalden JR; Harrer T
J Immunol; 1999 Mar; 162(6):3727-34. PubMed ID: 10092836
[TBL] [Abstract][Full Text] [Related]
17. A condition for successful escape of a mutant after primary HIV infection.
Monteiro LH; Gonçalves CH; Piqueira JR
J Theor Biol; 2000 Apr; 203(4):399-406. PubMed ID: 10736216
[TBL] [Abstract][Full Text] [Related]
18. Dynamics of immune escape in HIV infection.
Wodarz D; Nowak MA
Wien Klin Wochenschr; 1999 Jun; 111(11):419-27. PubMed ID: 10420492
[TBL] [Abstract][Full Text] [Related]
19. Correlates of cytotoxic T-lymphocyte-mediated virus control: implications for immunosuppressive infections and their treatment.
Wodarz D; Nowak MA
Philos Trans R Soc Lond B Biol Sci; 2000 Aug; 355(1400):1059-70. PubMed ID: 11186307
[TBL] [Abstract][Full Text] [Related]
20. Dendritic cell vaccination induces cross-reactive cytotoxic T lymphocytes specific for wild-type and natural variant human immunodeficiency virus type 1 epitopes in HLA-A*0201/Kb transgenic mice.
Abdel-Motal UM; Friedline R; Poligone B; Pogue-Caley RR; Frelinger JA; Tisch R
Clin Immunol; 2001 Oct; 101(1):51-8. PubMed ID: 11580226
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
